Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7647
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMerzenich, Hiltrud-
dc.contributor.authorBaaken, Dan-
dc.contributor.authorSchmidt, Marcus-
dc.contributor.authorBekes, Inga-
dc.contributor.authorSchwentner, Lukas-
dc.contributor.authorJanni, Wolfgang-
dc.contributor.authorWoeckel, Achim-
dc.contributor.authorBartkowiak, Detlef-
dc.contributor.authorWiegel, Thomas-
dc.contributor.authorBlettner, Maria-
dc.contributor.authorWollschläger, Daniel-
dc.contributor.authorSchmidberger, Heinz-
dc.date.accessioned2022-08-30T10:26:15Z-
dc.date.available2022-08-30T10:26:15Z-
dc.date.issued2022-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7661-
dc.description.abstractPurpose Radiotherapy (RT) was identified as a risk factor for long-term cardiac effects in breast cancer patients treated until the 1990s. However, modern techniques reduce radiation exposure of the heart, but some exposure remains unavoidable. In a retrospective cohort study, we investigated cardiac mortality and morbidity of breast cancer survivors treated with recent RT in Germany. Methods A total of 11,982 breast cancer patients treated between 1998 and 2008 were included. A mortality follow-up was conducted until 06/2018. In order to assess cardiac morbidity occurring after breast cancer treatment, a questionnaire was sent out in 2014 and 2019. The effect of breast cancer laterality on cardiac mortality and morbidity was investigated as a proxy for radiation exposure. We used Cox Proportional Hazards regression analysis, taking potential confounders into account. Results After a median follow-up time of 11.1 years, there was no significant association of tumor laterality with cardiac mortality in irradiated patients (hazard ratio (HR) for left-sided versus right-sided tumor 1.09; 95% confidence interval (CI) 0.85–1.41). Furthermore, tumor laterality was not identified as a significant risk factor for cardiac morbidity (HR = 1.05; 95%CI 0.88–1.25). Conclusions Even though RT for left-sided breast cancer on average incurs higher radiation dose to the heart than RT for right-sided tumors, we found no evidence that laterality is a strong risk factor for cardiac disease after contemporary RT. However, larger sample sizes, longer follow-up, detailed information on individual risk factors and heart dose are needed to assess clinically manifest late effects of current cancer therapy.en_GB
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleCardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients : a retrospective cohort study in Germany (ESCaRa)en_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7647-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleBreast cancer research and treatmentde
jgu.journal.volume191de
jgu.pages.start147de
jgu.pages.end157de
jgu.publisher.year2022-
jgu.publisher.nameSpringer Science + Business Media B.V.de
jgu.publisher.placeDordrecht u.a.de
jgu.publisher.issn1573-7217de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1007/s10549-021-06412-3de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
cardiac_late_effects_after_mo-20220829130447985.pdf961.79 kBAdobe PDFView/Open